1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Antiretroviral treatment for HIV infection : Swedish recommendations 2019
- 2018
- Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
-
Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
Andersson, Emmi ; Nordquist, Agnes ; Esbjörnsson, Joakim LU
;
Flamholc, Leo
LU
;
Gisslén, Magnus
;
Hejdeman, Bo
;
Marrone, Gaetano
;
Norrgren, Hans
LU
;
Svedhem, Veronica
and
Wendahl, Suzanne
, et al.
(2018)
In AIDS
32(7).
p.877-884
Mark
- 2017
-
Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment
Elvstam, Olof LU
;
Medstrand, Patrik
LU
;
Yilmaz, Aylin
;
Isberg, Per Erik
LU
;
Gisslen, Magnus
and
Bjorkman, Per
LU
(2017)
In PLoS ONE
12(7).
Mark
- Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients
- Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway
- 2016
- Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels
-
Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.
Karlsson, Ulf LU ; Repits, Johanna LU ; Antonsson, Liselotte LU ; Cederfjäll, Erik LU ; Ljungberg, Bengt LU ; Ålenius, Martin ; Sabirsh, Alan LU ; Gisslen, Magnus ; Esbjörnsson, Joakim LU
and
Jansson, Marianne
LU
(2016)
In Journal of Acquired Immune Deficiency Syndromes
71(3).
Mark
- 2015
- Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.
- 2014
- Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013